Clinical trial
Composite Health Assessment Risk Model (CHARM) for Older Adults: Applying Pre-Transplant Comorbidity, Geriatric Assessment, and BioMarkers on Non-Relapse Mortality After Allogeneic Transplant (BMT CTN 1704)
NCT03992352 is registered in ClinicalTrials.gov with Center for International Blood and Marrow Transplant Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Composite Health Assessment Risk Model (CHARM) for Older Adults: Applying Pre-Transplant Comorbidity, Geriatric Assessment, and BioMarkers on Non-Relapse Mortality After Allogeneic Transplant (BMT CTN 1704)
- Lead sponsor
- Center for International Blood and Marrow Transplant Research
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 19, 2019
- Completion date
- May 30, 2023
- Enrollment
- 1,229 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.
hematologic malignancy